Download Citation
Article Source:
Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen
Bertheau P,
Turpin E,
Rickman DS,
Espié M,
de Reyniès A,
et al.
(2007)
Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen.
PLOS Medicine 4(3): e90.
https://doi.org/10.1371/journal.pmed.0040090